‘All of Us’ Program Taps New Partners to Promote Trial Diversity

The All of Us Research Program has awarded $8.7 million to seven national community partners to strengthen recruitment of participants and researchers from populations that are underrepresented in biomedical research. As part of the new award, the partners will build networks of community organizations and engage with the program’s healthcare provider organizations and other partners to […]

Many Unproven Cancer Drugs Continue to be Recommended for Patients

One third of cancer drugs that received accelerated approval from the U.S. Food and Drug Administration (FDA) continue to be recommended in clinical guidelines after their confirmatory clinical trials fail to show improvement on their primary endpoints, finds a new study published in The BMJ. The researchers say clinical guidelines “should better align with the […]

Scientists Create Labor-Saving Automated Method for Studying Electronic Health Records

In an article published in the journal Patterns, scientists at the Icahn School of Medicine at Mount Sinai described the creation of an automated, artificial intelligence-based algorithm that can learn to read patient data from electronic health records. In a side-by-side comparison, they showed that their method, called Phe2vec, accurately identified patients with certain diseases […]

Pete Fronte, President/CEO, Altura

Virtual Clinical Trials: Take the First Step!

On Behalf of Altura – Virtual Clinical Trials (VCTs) may not be the norm anytime soon, but proactive sponsors, study sites, and healthcare systems that conduct clinical trials and health studies can begin to take steps to prepare for the future. VCTs, or remote/decentralized clinical trials, utilize digital tools such as mobile phone apps, electronic […]

Reporting Requirements Fall Short for Black and Hispanic Patients in Acute Leukemia Trials

Requirements instituted to address racial and ethnic disparities in clinical trial enrollment did not lead to increased inclusion of Black and Hispanic participants in clinical acute leukemia research, according to a new study in the journal Blood Advances. Researchers said the findings underscore the need to create targeted enrollment diversification strategies to ensure all patients […]